Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for antigen receptor t cells
Most Correlated Studies
- Regulatory T (Treg) cells and conventional T cells reponses to different factors and conditions
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- CD4 T-cells with MTOR, ZAP70 silencing, or treated with Rapamycin or Cyclosporin A
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
Most Relevant Literature
- Enhanced T cell receptor specificity through framework engineering.
- Parsing digital or analog TCR performance through piconewton forces.
- Human TCR repertoire in cancer.
- Advances in preclinical TCR characterization: leveraging cell avidity to identify functional TCRs.
- Mathematical models of TCR initial triggering.
Most Relevant Clinical Trials
- AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma
- Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma
- Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T C…
- Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma T…
- Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gl…
